Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Deutsche Medizinische Wochenschrift (1946)|April 24, 2024
[Mucormycosis in the time of COVID-19: risks and challenges]Danila Seidel, Ertan Sal, Julia A Nacov, et al.
Biomedicine Hub|April 18, 2022
Initial Proportion and Dynamic of B.1.1.7 SARS-CoV-2 in a Large City in the West of GermanySimon D Herkenrath, Kyrill Boschung, Julia A Nacov, et al.
Orthopaedic Journal of Sports Medicine|April 28, 2025
The Primary Stability of Arthroscopic Subscapularis Tendon Repair Depends on the Suture Technique: A Biomechanical Evaluation of 4 Different Repair TechniquesJulia A Nacov, Sandra Kammerlohr, Manfred Staat, et al.
Molecular Aspects of Medicine|May 19, 2023
Antifungal prophylaxis and pre-emptive therapy: When and how?Rosanne Sprute, Julia A Nacov, Dionysios Neofytos, et al.
Infection|May 28, 2024
Challenges in assessing the immunization status of adults in Germany-lessons from a population-based VACCELERATE survey on polio vaccinationJulia A Nacov, Jannik Stemler, Jon Salmanton-García, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 19, 2026
Self-testing for 5 respiratory viruses in adults ≥50 years of age in Germany for longitudinal monitoring of community-acquired acute respiratory infectionsJulia A Nacov, Jon Salmanton-García, Julia Jakobs, et al.
JMIR Research Protocols|May 26, 2025
Immunogenicity of COVID-19 Vaccination in Immunocompromised Patients (Auto-COVID-VACC): Protocol for Multicenter Prospective Noninterventional StudyLouise Marie Cremer, Ullrich Bethe, Peter Borchmann, et al.
Frontiers in Public Health|September 19, 2025
Self-testing for 5 respiratory viruses in adult VACCELERATE volunteers in Germany-a pilot study on multi-pathogen rapid antigen testing to monitor community-acquired acute respiratory infectionsJulia A Nacov, Jon Salmanton-García, Sarah Grimm, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|July 11, 2024
Immunogenicity, reactogenicity, and safety of a second booster with BNT162b2 or full-dose mRNA-1273: A randomized VACCELERATE trial in adults aged ≥75 years (EU-COVAT-1-AGED Part B)Jannik Stemler, Lusine Yeghiazaryan, Christoph Stephan, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|February 8, 2026
Immunogenicity, reactogenicity and safety to assess booster vaccinations with BNT162b2 or double-dose mRNA-1273 in adults ≥75 years (EU-COVAT-1-AGED) - final reportJannik Stemler, Lusine Yeghiazaryan, Christoph Stephan, et al.
Pageof 1